Wall Street analyst estimates for None (SRTS): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 6 |
| Hold | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 9 |
| Avg rating (1-5) | 0.67 |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.8M | $20.6M | $26.4M | $27.3M | $9.6M | $27.0M | $44.5M | $24.4M | $41.8M | $27.5M |
| Cost of Revenue | $5.0M | $6.8M | $9.5M | $9.7M | $4.3M | $10.1M | $14.9M | $10.3M | $17.4M | $15.6M |
| Gross Profit | $9.8M | $13.8M | $16.9M | $17.6M | $5.2M | $17.0M | $29.6M | $14.1M | $24.4M | $11.9M |
| Research & Development | $1.8M | $5.5M | $6.3M | $6.4M | $4.2M | $3.4M | $3.5M | $3.7M | $4.2M | $7.8M |
| Selling, General & Admin | $8.4M | $12.0M | $12.7M | $13.1M | $9.3M | $9.4M | $11.3M | $10.8M | $12.1M | $14.4M |
| Operating Expenses | $10.2M | $17.5M | $18.9M | $19.5M | $13.5M | $12.9M | $14.8M | $14.4M | $16.3M | $22.2M |
| Operating Income | -$363119 | -$3.7M | -$2.0M | -$2.0M | -$8.2M | $4.1M | $14.8M | -$382000 | $8.1M | -$10.3M |
| EBITDA | $13002 | -$3.3M | -$1.2M | -$1.2M | -$6.1M | $4.7M | $28.5M | $1.1M | $9.5M | -$9.2M |
| Interest Expense | $21867 | $68881 | $156685 | 0 | $14000 | $1000 | $2000 | 0 | 0 | 0 |
| Pre-tax Income | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $28.0M | $652000 | $9.0M | -$9.6M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | $3.7M | $167000 | $2.4M | -$1.9M |
| Net Income | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $24.2M | $485000 | $6.6M | -$7.7M |
| EPS | $-0.03 | $-0.28 | $-0.14 | $-0.07 | $-0.42 | $0.25 | $1.47 | $0.03 | $0.41 | $-0.47 |
| EPS (Diluted) | $-0.03 | $-0.28 | $-0.14 | $-0.07 | $-0.42 | $0.25 | $1.46 | $0.03 | $0.41 | $-0.47 |
| Shares Outstanding (Diluted) | $12.0M | $13.2M | $14.1M | $16.2M | $16.4M | $16.5M | $16.6M | $16.3M | $16.4M | $16.3M |
Price
| Price | $3.07 |
| Market Cap | $51M |
Related companies: BDMD · CTSO · ICCM · IPSC · KPTI · MDAI · MDCX
More sections of SRTS: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks